众生药业: 第八届董事会独立董事专门会议2025年第二次会议审核意见

Core Viewpoint - The independent directors of Guangdong Zhongsheng Pharmaceutical Co., Ltd. approved the proposal for redeeming part of the equity of a controlling subsidiary and related transactions, indicating compliance with relevant regulations and fairness in the transaction process [1][2]. Group 1 - The independent directors' meeting was held on March 31, 2025, with all three independent directors present and participating in the decision-making process [1]. - The proposal for redeeming part of the equity was passed with a unanimous vote of 3 in favor, 0 against, and 0 abstentions [1]. - The transaction adheres to the principles of openness, fairness, and justice, ensuring that the transaction price is clear and fair, and does not harm the interests of the company and its shareholders [2]. Group 2 - The proposal will be submitted to the 19th meeting of the 8th Board of Directors for further review [2].